Moon J. Noh, Ph.D.

Moon J. Noh, Ph.D.

Chief Executive Officer

  • TG-C US FDA 임상1, 2상 완료
  • 서울대 미생물학 학사 ('89) / 카이스트 생명과학 박사 ('95)
권순욱

권순욱

Vice President

  • Kolon TissueGene, Inc. CFO ('17~현재)
  • (주)코오롱 경영관리실 상무 ('04~'17)
  • (주)대우 국제금융부 ('93~'00)
  • 고려대 경제학 학사 ('92)
김정인

김정인

Chief Financial Officer

  • Kolon TissueGene, Inc.('21~현재)
  • ㈜ 코오롱 경영관리실('13~'21)
  • 국민대학교 수학과 학사('02)
Sun Jin Kim, MD, PhD

Sun Jin Kim, MD, PhD

Chief Medical Officer

  • Kolon TissueGene, Inc., Chief Medical Officer (’21 ~ 현재)
  • Platbio Inc. 대표이사 ('18 ~ 현재)
  • Executive Vice President, Hanmi Pharm Co., Ltd ('17~'18)
  • Seoul National University College of Medicine, Seoul, MD
  • Seoul National University Graduate School, Seoul, PHD, Medical Science
Diana M. Halim, M.S.

Diana M. Halim, M.S.

Vice President of Clinical and Regulatory Affairs

Diana M. Halim joined Kolon TissueGene, Inc. in January 2020 as Senior Director of Regulatory Affairs and shortly thereafter became Vice President of Clinical and Regulatory Affairs. She previously served as the Director of Regulatory Affairs at RRD International, LLC, Sucampo Pharmaceuticals, Inc., and AnGes, Inc. She received her B.A. degree in English/Biology from George Washington University, Washington, DC and her M.S. degree in Biotechnology from Johns Hopkins University, Baltimore, MD.